BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  ImmunoPrecise Antibodies and a Global Biotechnology Leader Enter into a USD $8M-$10M Partnership for the Development of Novel Cancer Therapeutics.

  March 13, 2025

   · 

  4 min read
• Press Releases

  PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis

  March 13, 2025

   · 

  4 min read
• Press Releases

  Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

  March 13, 2025

   · 

  5 min read
• Press Releases

  Rett Syndrome Research Trust Appoints Amy Gilliland to its Board of Trustees

  March 13, 2025

   · 

  3 min read
• Press Releases

  OS Therapies Awarded OST-HER2 Clinical Trial Data Presentation at MIB Agents FACTOR Osteosarcoma Conference

  March 13, 2025

   · 

  4 min read
• Press Releases

  Novartis Pharmaceuticals and Folia Health Partner on Innovative App-Based Study to Assess Real-World Experience of IgA Nephropathy

  March 13, 2025

   · 

  3 min read
• Press Releases

  Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

  March 13, 2025

   · 

  5 min read
• Press Releases

  PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer

  March 13, 2025

   · 

  7 min read
• Press Releases

  Xenetic Biosciences, Inc. Presents Positive Preclinical Data Underscoring the Potential of DNase I as an Adjunctive Treatment to Enhance Immunotherapeutic Responses

  March 13, 2025

   · 

  7 min read
• Press Releases

  HAYA Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer

  March 13, 2025

   · 

  3 min read